Related Experiment Videos
New pathophysiological mechanisms in irritable bowel syndrome
G Barbara1, R De Giorgio, V Stanghellini
1Department of Internal Medicine and Gastroenterology, University of Bologna, Italy. gbarbara@med.unibo.it
Alimentary Pharmacology & Therapeutics
|September 1, 2004
Summary
Irritable bowel syndrome (IBS) involves gut dysfunction, pain, and altered bowel habits. New research explores factors like gas, brain signaling, infections, and gut microbiota in IBS pathophysiology.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Immunology
Background:
- Irritable bowel syndrome (IBS) is a complex functional disorder.
- Key factors include gut motility, visceral hypersensitivity, and psychosocial elements.
- Emerging evidence points to novel mechanisms influencing IBS.
Purpose of the Study:
- To explore recently identified factors contributing to IBS pathophysiology.
- To understand the interaction of novel mechanisms with classical IBS pathways.
- To identify potential targets for new IBS therapies.
Main Methods:
- Review of current literature on IBS mechanisms.
- Analysis of proposed roles for gas trapping, altered brain processing, and post-infectious triggers.
- Examination of evidence for mucosal inflammation, gut microbiota, and genetic factors.
Main Results:
- Gas trapping and bowel distension contribute to bloating and pain.
- Altered brain activity in response to rectal stimuli indicates modified afferent processing.
- Post-infectious IBS involves impaired inflammatory response regulation.
- Low-grade inflammation and mast cell activation in the colon are implicated in pain perception.
- Changes in gut microflora, serotonin metabolism, and genetics are suggested contributors.
Conclusions:
- Novel mechanisms including gas dynamics, neuro-immune interactions, and gut microbiome alterations offer a deeper understanding of IBS.
- These findings pave the way for developing targeted therapies for IBS patients.